-
Something wrong with this record ?
Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms
T. Smejkalova, M. Korinek, J. Krusek, B. Hrcka Krausova, M. Candelas Serra, D. Hajdukovic, E. Kudova, H. Chodounska, L. Vyklicky
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1968 to 1 year ago
Europe PubMed Central
from 1968 to 1 year ago
Medline Complete (EBSCOhost)
from 2002-01-01 to 1 year ago
Wiley Free Content
from 1997 to 1 year ago
PubMed
33988248
DOI
10.1111/bph.15529
Knihovny.cz E-resources
- MeSH
- HEK293 Cells MeSH
- Rats MeSH
- Glutamic Acid MeSH
- Humans MeSH
- Neurosteroids * MeSH
- Pregnanolone * pharmacology MeSH
- Sulfates MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND AND PURPOSE: Neurosteroids influence neuronal function and have multiple promising clinical applications. Direct modulation of postsynaptic neurotransmitter receptors by neurosteroids is well characterized, but presynaptic effects remain poorly understood. Here, we report presynaptic glutamate release potentiation by neurosteroids pregnanolone and pregnanolone sulfate and compare their mechanisms of action to phorbol 12,13-dibutyrate (PDBu), a mimic of the second messenger DAG. EXPERIMENTAL APPROACH: We use whole-cell patch-clamp electrophysiology and pharmacology in rat hippocampal microisland cultures and total internal reflection fluorescence (TIRF) microscopy in HEK293 cells expressing GFP-tagged vesicle priming protein Munc13-1, to explore the mechanisms of neurosteroid presynaptic modulation. KEY RESULTS: Pregnanolone sulfate and pregnanolone potentiate glutamate release downstream of presynaptic Ca2+ influx, resembling the action of a phorbol ester PDBu. PDBu partially occludes the effect of pregnanolone, but not of pregnanolone sulfate. Calphostin C, an inhibitor that disrupts DAG binding to its targets, reduces the effect PDBu and pregnanolone, but not of pregnanolone sulfate, suggesting that pregnanolone might interact with a well-known DAG/phorbol ester target Munc13-1. However, TIRF microscopy experiments found no evidence of pregnanolone-induced membrane translocation of GFP-tagged Munc13-1, suggesting that pregnanolone may regulate Munc13-1 indirectly or interact with other DAG targets. CONCLUSION AND IMPLICATIONS: We describe a novel presynaptic effect of neurosteroids pregnanolone and pregnanolone sulfate to potentiate glutamate release downstream of presynaptic Ca2+ influx. The mechanism of action of pregnanolone, but not of pregnanolone sulfate, partly overlaps with that of PDBu. Presynaptic effects of neurosteroids may contribute to their therapeutic potential in the treatment of disorders of the glutamate system.
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic
Institute of Physiology Czech Academy of Sciences Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003543
- 003
- CZ-PrNML
- 005
- 20220127150122.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/bph.15529 $2 doi
- 035 __
- $a (PubMed)33988248
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Smejkalova, Tereza $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 245 10
- $a Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms / $c T. Smejkalova, M. Korinek, J. Krusek, B. Hrcka Krausova, M. Candelas Serra, D. Hajdukovic, E. Kudova, H. Chodounska, L. Vyklicky
- 520 9_
- $a BACKGROUND AND PURPOSE: Neurosteroids influence neuronal function and have multiple promising clinical applications. Direct modulation of postsynaptic neurotransmitter receptors by neurosteroids is well characterized, but presynaptic effects remain poorly understood. Here, we report presynaptic glutamate release potentiation by neurosteroids pregnanolone and pregnanolone sulfate and compare their mechanisms of action to phorbol 12,13-dibutyrate (PDBu), a mimic of the second messenger DAG. EXPERIMENTAL APPROACH: We use whole-cell patch-clamp electrophysiology and pharmacology in rat hippocampal microisland cultures and total internal reflection fluorescence (TIRF) microscopy in HEK293 cells expressing GFP-tagged vesicle priming protein Munc13-1, to explore the mechanisms of neurosteroid presynaptic modulation. KEY RESULTS: Pregnanolone sulfate and pregnanolone potentiate glutamate release downstream of presynaptic Ca2+ influx, resembling the action of a phorbol ester PDBu. PDBu partially occludes the effect of pregnanolone, but not of pregnanolone sulfate. Calphostin C, an inhibitor that disrupts DAG binding to its targets, reduces the effect PDBu and pregnanolone, but not of pregnanolone sulfate, suggesting that pregnanolone might interact with a well-known DAG/phorbol ester target Munc13-1. However, TIRF microscopy experiments found no evidence of pregnanolone-induced membrane translocation of GFP-tagged Munc13-1, suggesting that pregnanolone may regulate Munc13-1 indirectly or interact with other DAG targets. CONCLUSION AND IMPLICATIONS: We describe a novel presynaptic effect of neurosteroids pregnanolone and pregnanolone sulfate to potentiate glutamate release downstream of presynaptic Ca2+ influx. The mechanism of action of pregnanolone, but not of pregnanolone sulfate, partly overlaps with that of PDBu. Presynaptic effects of neurosteroids may contribute to their therapeutic potential in the treatment of disorders of the glutamate system.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kyselina glutamová $7 D018698
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a neurosteroidy $7 D000081227
- 650 12
- $a pregnanolon $x farmakologie $7 D011280
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a sírany $7 D013431
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Korinek, Miloslav $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Krusek, Jan $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Hrcka Krausova, Barbora $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Candelas Serra, Miriam $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Hajdukovic, Dragana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Chodounska, Hana $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vyklicky, Ladislav $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00009383 $t British journal of pharmacology $x 1476-5381 $g Roč. 178, č. 19 (2021), s. 3888-3904
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33988248 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150118 $b ABA008
- 999 __
- $a ok $b bmc $g 1751105 $s 1154692
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 178 $c 19 $d 3888-3904 $e 20210622 $i 1476-5381 $m British journal of pharmacology $n Br J Pharmacol $x MED00009383
- LZP __
- $a Pubmed-20220113